Did you know that most new FDA-approved drugs in 2023 were small molecules? These are essential for many pharmaceutical companies and biotechs to find new treatments. At NUVISAN, we provide tailored chemical libraries with millions of compounds and various testing methods to kickstart drug discovery. Watch Dr. Benjamin Bader, Head of Screening, and Dr. Stefan Werner, Director of Life Science Chemistry, unveil our unique libraries and how we find potential novel drugs using high-throughput screening (HTS). Find out more about SMOL libraries at NUVISAN, our assay technologies and project workflows for virtual screening. Explore our latest case study for how HTS can deliver novel leads. Screening the right compounds with the right assays by the right scientists is key for every drug discovery project.
